Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05255757 · ClinicalTrials.gov registry record · NA
Network Interventions to Reduce Disparities in Living Kidney Donation
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT05255757: Completed NA study, sponsored by Penn State University.
NCT05255757 is a NA study that has completed, run by Penn State University. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05255757, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. This project will examine how network characteristics are associated with eventual living donor kidney transplant outcomes and test the efficacy of evidence-based interventions designed to assist kidney transplant candidates in participant donor search on a multi-center scale.
Primary Outcome
Living donor kidney transplant received by patient
Interventions
- BEHAVIORAL Script Intervention
- BEHAVIORAL Search Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
What the finished NCT05255757 record still lists
NCT05255757 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Script Intervention is the first listed.
NCT05255757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05255757 about?
NCT05255757 is a clinical study titled "Network Interventions to Reduce Disparities in Living Kidney Donation". For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. This project will examine how network characteristics are associated with eventual living donor ...
What is the current status of trial NCT05255757?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2021-10-12. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05255757?
The interventions under investigation include: Script Intervention (BEHAVIORAL), Search Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05255757?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05255757's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI